MCUJF
Price
$0.91
Change
+$0.01 (+1.11%)
Updated
Jun 26 closing price
Capitalization
11.29M
MEDXF
Price
$2.27
Change
-$0.03 (-1.30%)
Updated
Jul 3 closing price
Capitalization
31.92M
32 days until earnings call
Interact to see
Advertisement

MCUJF vs MEDXF

Header iconMCUJF vs MEDXF Comparison
Open Charts MCUJF vs MEDXFBanner chart's image
Medicure
Price$0.91
Change+$0.01 (+1.11%)
Volume$636
Capitalization11.29M
Medexus Pharmaceuticals
Price$2.27
Change-$0.03 (-1.30%)
Volume$6.76K
Capitalization31.92M
MCUJF vs MEDXF Comparison Chart in %
Loading...
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MCUJF vs. MEDXF commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MCUJF is a Hold and MEDXF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (MCUJF: $0.91 vs. MEDXF: $2.27)
Brand notoriety: MCUJF and MEDXF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: MCUJF: 100% vs. MEDXF: 90%
Market capitalization -- MCUJF: $11.29M vs. MEDXF: $31.92M
MCUJF [@Pharmaceuticals: Other] is valued at $11.29M. MEDXF’s [@Pharmaceuticals: Other] market capitalization is $31.92M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MCUJF’s FA Score shows that 1 FA rating(s) are green whileMEDXF’s FA Score has 1 green FA rating(s).

  • MCUJF’s FA Score: 1 green, 4 red.
  • MEDXF’s FA Score: 1 green, 4 red.
According to our system of comparison, MEDXF is a better buy in the long-term than MCUJF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MCUJF’s TA Score shows that 3 TA indicator(s) are bullish while MEDXF’s TA Score has 4 bullish TA indicator(s).

  • MCUJF’s TA Score: 3 bullish, 4 bearish.
  • MEDXF’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both MCUJF and MEDXF are a bad buy in the short-term.

Price Growth

MCUJF (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while MEDXF (@Pharmaceuticals: Other) price change was -2.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

MEDXF is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MEDXF($31.9M) has a higher market cap than MCUJF($11.3M). MEDXF has higher P/E ratio than MCUJF: MEDXF (26.67) vs MCUJF (12.53). MCUJF YTD gains are higher at: 47.000 vs. MEDXF (-5.963). MEDXF has higher annual earnings (EBITDA): 14.6M vs. MCUJF (3.24M). MEDXF has more cash in the bank: 13.1M vs. MCUJF (4.93M). MCUJF has less debt than MEDXF: MCUJF (777K) vs MEDXF (70.1M). MEDXF has higher revenues than MCUJF: MEDXF (108M) vs MCUJF (23M).
MCUJFMEDXFMCUJF / MEDXF
Capitalization11.3M31.9M35%
EBITDA3.24M14.6M22%
Gain YTD47.000-5.963-788%
P/E Ratio12.5326.6747%
Revenue23M108M21%
Total Cash4.93M13.1M38%
Total Debt777K70.1M1%
FUNDAMENTALS RATINGS
MCUJF vs MEDXF: Fundamental Ratings
MCUJF
MEDXF
OUTLOOK RATING
1..100
5081
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
66
Overvalued
PROFIT vs RISK RATING
1..100
8492
SMR RATING
1..100
9364
PRICE GROWTH RATING
1..100
3741
P/E GROWTH RATING
1..100
292
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MCUJF's Valuation (62) in the null industry is in the same range as MEDXF (66). This means that MCUJF’s stock grew similarly to MEDXF’s over the last 12 months.

MCUJF's Profit vs Risk Rating (84) in the null industry is in the same range as MEDXF (92). This means that MCUJF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's SMR Rating (64) in the null industry is in the same range as MCUJF (93). This means that MEDXF’s stock grew similarly to MCUJF’s over the last 12 months.

MCUJF's Price Growth Rating (37) in the null industry is in the same range as MEDXF (41). This means that MCUJF’s stock grew similarly to MEDXF’s over the last 12 months.

MEDXF's P/E Growth Rating (2) in the null industry is in the same range as MCUJF (29). This means that MEDXF’s stock grew similarly to MCUJF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MCUJFMEDXF
RSI
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
69%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
61%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
62%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
N/A
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
57%
Bullish Trend 3 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
MCUJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MEDXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSSMY6.630.18
+2.79%
Misumi Group, Inc.
SGBLY13.150.22
+1.70%
Standard Bank Group Ltd.
CSOL0.01N/A
N/A
China Solar & Clean Energy Solutions, Inc.
FNCHF1.75N/A
N/A
FINEOS CORP HLDG PLC.
FCLIF0.16N/A
N/A
Full Circle Lithium Corp.

MCUJF and

Correlation & Price change

A.I.dvisor tells us that MCUJF and PAIOF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MCUJF and PAIOF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MCUJF
1D Price
Change %
MCUJF100%
N/A
PAIOF - MCUJF
21%
Poorly correlated
N/A
LVRLF - MCUJF
14%
Poorly correlated
-8.29%
MVMDF - MCUJF
11%
Poorly correlated
-5.04%
MGWFF - MCUJF
10%
Poorly correlated
N/A
MEDXF - MCUJF
4%
Poorly correlated
-1.27%
More

MEDXF and

Correlation & Price change

A.I.dvisor tells us that MEDXF and LBTSF have been poorly correlated (+10% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MEDXF and LBTSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MEDXF
1D Price
Change %
MEDXF100%
-1.27%
LBTSF - MEDXF
10%
Poorly correlated
N/A
MRMD - MEDXF
9%
Poorly correlated
+0.70%
MKGAF - MEDXF
7%
Poorly correlated
+0.12%
MCUJF - MEDXF
4%
Poorly correlated
N/A
MEDIF - MEDXF
2%
Poorly correlated
-3.53%
More